Minerva Neurosciences Share Price (NASDAQ: NERV)

$2.41

▲

0.03

(1.26%)

Last updated on August 30, 2025 at 1:19 am IST

$₹

Check the interactive Minerva Neurosciences Stock chart to analyse performance

Minerva Neurosciences stock performance

as on August 30, 2025 at 1:19 am IST

Today's Low:$2.41
Today's High:$2.41
$2.41
0.0%
Downside
Day's Volatility :0.0%
Upside
0.0%
52 Weeks Low:$1.15
52 Weeks High:$3.00
$2.41
52.28%
Downside
52 Weeks Volatility :61.67%
Upside
19.67%

Minerva Neurosciences Stock Returns

Period	Minerva Neurosciences, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	54.49%	3.6%	0.0%
6 Months	57.52%	-7.7%	0.0%
1 Year	-9.06%	-12.6%	0.0%
3 Years	-75.1%	10.2%	-4.1%

Minerva Neurosciences, Inc. Key Stats

Check Minerva Neurosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.38
Open	$2.41
Today's High	$2.41
Today's Low	$2.41
Market Capitalization	$16.6M
Today's Volume	$8.9K
52 Week High	$3.0
52 Week Low	$1.15
Revenue TTM	$0.0
EBITDA	$-16.2M
Earnings Per Share (EPS)	$1.48
PE Ratio	1.61
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-675.09%

Stock Returns calculator for Minerva Neurosciences Stock including INR - Dollar returns

The Minerva Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Minerva Neurosciences investment value today

Current value as on today

₹96,228

Returns

₹3,772

(-3.77%)

Returns from Minerva Neurosciences Stock

₹9,057 (-9.06%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Minerva Neurosciences Stock

-31%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Minerva Neurosciences Stock from India on INDmoney has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Minerva Neurosciences, Inc.

Name
Holdings %
Name
Holdings %
Federated Hermes Inc
19.32%
Vanguard Group Inc
3.60%
Renaissance Technologies Corp
1.63%
Geode Capital Management, LLC
1.10%
BlackRock Inc
1.04%
Apella Capital, LLC
0.30%

Analyst Recommendation on Minerva Neurosciences Stock

Rating

Trend

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Minerva Neurosciences(by analysts ranked 0 to 5 stars)

Minerva Neurosciences Share Price Target

What analysts predicted

Upside of 107.47%

Target:

$5.00

Current:

$2.41

Minerva Neurosciences share price target is $5.00, a slight Upside of 107.47% compared to current price of $2.41 as per analysts' prediction.

Minerva Neurosciences Stock Insights

Price Movement
In the last 1 month, NERV stock has moved up by 28.9%
NERV vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 81.9%
NERV vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 194.6%

Minerva Neurosciences Technicals Summary

Sell

Neutral

Buy

Minerva Neurosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Minerva Neurosciences, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Minerva Neurosciences, Inc.	26.01%	57.52%	-9.06%	-75.1%	-90.12%
Regeneron Pharmaceuticals, Inc.	3.92%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-15.42%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	11.08%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Minerva Neurosciences, Inc.	1.61	1.61	0.0	-2.68	-6.75	-0.26	NA	-4.59
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Minerva Neurosciences, Inc.	Sell	$16.6M	-90.12%	1.61	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Organization	Minerva Neurosciences
Employees	8
CEO	Dr. Remy Luthringer Ph.D.
Industry	Health Technology

Key Management of Minerva Neurosciences, Inc.

Name	Title
Dr. Remy Luthringer Ph.D.	Executive Chairman & CEO
Mr. Geoffrey Robin Race F.C.M.A., M.B.A.	President
Mr. Frederick W. Ahlholm CPA	Senior VP, CFO & Secretary
Mr. Joseph Reilly	Senior VP & COO
Mr. William B. Boni	Vice President of Investor Relations & Corporate Communications
Prof. Michael Davidson M.D.	Chief Medical Officer

Important FAQs about investing in NERV Stock from India :

What is Minerva Neurosciences share price today?

Minerva Neurosciences share price today is $2.41 as on August 30, 2025 at 1:19 am IST at the close of the market. Minerva Neurosciences share today touched a day high of $2.41 and a low of $2.41.

What is the 52 week high and 52 week low for Minerva Neurosciences share?

Minerva Neurosciences share touched a 52 week high of $3.00 and a 52 week low of $1.15. Minerva Neurosciences stock price today i.e. August 30, 2025 at 1:19 am IST is closed at $2.41, lower by 19.67% versus the 52 week high.

How to invest in Minerva Neurosciences Stock (NERV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Minerva Neurosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Minerva Neurosciences Shares that will get you 0.6224 shares as per Minerva Neurosciences share price of $2.41 per share as on August 30, 2025 at 1:19 am IST.

What is the minimum amount required to buy Minerva Neurosciences Stock (NERV) from India?

Indian investors can start investing in Minerva Neurosciences (NERV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Minerva Neurosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Minerva Neurosciences share’s latest price of $2.41 as on August 30, 2025 at 1:19 am IST, you will get 4.1494 shares of Minerva Neurosciences. Learn more about fractional shares .

What are the returns that Minerva Neurosciences has given to Indian investors in the last 5 years?

Minerva Neurosciences stock has given -90.12% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?